Tech Company Financing Transactions

Evalve Funding Round

Abbott Laboratories, ABS Capital Partners and BB Biotech Ventures invested in a $60 million Series D capital raise for Evalve. The financing round was announced on 12/5/2007.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Medical Devices & Instruments

Mailing Address

4045 Campbell Ave
Menlo Park, CA 94025
USA

Phone

(650) 330-8100

Website

www.evalveinc.com

Email Address

[email protected]

Overview

Evalve, Inc. is a leader in innovative devices for the endovascular repair of cardiac valves. The company's initial products are intended to reduce the risks, trauma and costs associated with current open, arrested heart surgical options.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ferolyn Powell

        

Chief Financial Officer

Doug Hughes

        

Vice President

Jonathan Feuchtwang

        

Vice President

Jan Komtebedde

        

VP - Operations

Bunty Banerjee

        

VP - R & D

Troy Thornton

        

VP - Regulatory Affairs

Liz McDermott

        

VP - Sales

Sean Cleary

        

VP - Sales

Chris Richardson

        

Browse more venture capital transactions:

Prev: 12/5/2007: Natera venture capital transaction
Next: 12/5/2007: ClickTale venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary